FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3124193465> ?p ?o ?g. }

• W3124193465 endingPage "1066" @default.
• W3124193465 startingPage "1057" @default.
• W3124193465 abstract "Abstract Background Oral sodium zirconium cyclosilicate (SZC) is a novel potassium binder capable of achieving a rapid reduction of serum potassium (sK + ) and maintaining a long-term normokalemia. We undertook a meta-analysis to summarize and evaluate the effects surrounding SZC in patients with hyperkalemia. Method We searched data sources from MEDLINE (from 1950 to Sep 2020), EMBASE (from 1970 to Sep 2020), and the Cochrane Library database (from 1950 to Sep 2020) for eligible studies. All randomized controlled trials (RCTs) regarding comparison of therapeutic effects of SZC in hyperkalemia participants were included. Results Seven studies, including 1697 patients with hyperkalemia, were analyzed. SZC significantly reduced mean sK + (−0.42 mmol/L; 95% CI: −0.63 to −0.20 mmol/L, p = 0.0001) compared with placebo, with a significantly greater proportion of patients with normokalemia (RR 3.48, 95% CI 1.49 to 8.11, p = 0.004). Subgroup analyses showed that the longer durations of SZC treatment, the greater magnitudes of potassium reduction when compared with those of placebo ( p between subgroups = 0.01) at correction phase. Besides, it also demonstrated sK + tended to decrease more in patients who got longer treatment or larger dosage of SZC at maintenance phase; however, the difference did not reach statistical significance. Additionally, the drug was equally effective in studies with larger than 50% of patients with chronic kidney disease (CKD) or diabetes or patients using renin-angiotensin aldosterone system inhibitor (RAAS) inhibitors (all p < 0.05). The risk of edema (4.30, 1.17 to 15.84; p = 0.03) in SZC group was higher than those of placebo group. No statistically significant differences in the risks of other adverse events were observed between the two groups. Conclusions SZC effectively decreased the sK + level in patients with hyperkalemia within 48 h and had benefits in the long-term control of serum potassium in patients who continued to receive SZC with a favorable safety profile from available data." @default.
• W3124193465 created "2021-02-01" @default.
• W3124193465 creator A5004296173 @default.
• W3124193465 creator A5005417134 @default.
• W3124193465 creator A5005505761 @default.
• W3124193465 creator A5033771456 @default.
• W3124193465 creator A5040897632 @default.
• W3124193465 creator A5046945471 @default.
• W3124193465 creator A5054155328 @default.
• W3124193465 creator A5054797283 @default.
• W3124193465 creator A5066402029 @default.
• W3124193465 creator A5076278100 @default.
• W3124193465 date "2021-01-18" @default.
• W3124193465 modified "2023-10-14" @default.
• W3124193465 title "Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis" @default.
• W3124193465 cites W1973622329 @default.
• W3124193465 cites W1993617109 @default.
• W3124193465 cites W2008452717 @default.
• W3124193465 cites W2040456946 @default.
• W3124193465 cites W2041162893 @default.
• W3124193465 cites W2072577267 @default.
• W3124193465 cites W2100169278 @default.
• W3124193465 cites W2169077241 @default.
• W3124193465 cites W2192954951 @default.
• W3124193465 cites W2287126828 @default.
• W3124193465 cites W2303156287 @default.
• W3124193465 cites W2315765264 @default.
• W3124193465 cites W2581549156 @default.
• W3124193465 cites W2588017662 @default.
• W3124193465 cites W2737005781 @default.
• W3124193465 cites W2765960660 @default.
• W3124193465 cites W2781231576 @default.
• W3124193465 cites W2884647724 @default.
• W3124193465 cites W2886031306 @default.
• W3124193465 cites W2920857322 @default.
• W3124193465 cites W2946005791 @default.
• W3124193465 cites W2947065165 @default.
• W3124193465 cites W2949536534 @default.
• W3124193465 cites W2949981799 @default.
• W3124193465 cites W2979523141 @default.
• W3124193465 cites W2979632449 @default.
• W3124193465 cites W2982641788 @default.
• W3124193465 cites W3000260122 @default.
• W3124193465 cites W3005302717 @default.
• W3124193465 cites W3011740533 @default.
• W3124193465 cites W3018996899 @default.
• W3124193465 cites W3048116145 @default.
• W3124193465 doi "https://doi.org/10.1007/s10557-020-07134-2" @default.
• W3124193465 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8452568" @default.
• W3124193465 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33459923" @default.
• W3124193465 hasPublicationYear "2021" @default.
• W3124193465 type Work @default.
• W3124193465 sameAs 3124193465 @default.
• W3124193465 citedByCount "7" @default.
• W3124193465 countsByYear W31241934652021 @default.
• W3124193465 countsByYear W31241934652022 @default.
• W3124193465 countsByYear W31241934652023 @default.
• W3124193465 crossrefType "journal-article" @default.
• W3124193465 hasAuthorship W3124193465A5004296173 @default.
• W3124193465 hasAuthorship W3124193465A5005417134 @default.
• W3124193465 hasAuthorship W3124193465A5005505761 @default.
• W3124193465 hasAuthorship W3124193465A5033771456 @default.
• W3124193465 hasAuthorship W3124193465A5040897632 @default.
• W3124193465 hasAuthorship W3124193465A5046945471 @default.
• W3124193465 hasAuthorship W3124193465A5054155328 @default.
• W3124193465 hasAuthorship W3124193465A5054797283 @default.
• W3124193465 hasAuthorship W3124193465A5066402029 @default.
• W3124193465 hasAuthorship W3124193465A5076278100 @default.
• W3124193465 hasBestOaLocation W31241934651 @default.
• W3124193465 hasConcept C126322002 @default.
• W3124193465 hasConcept C126894567 @default.
• W3124193465 hasConcept C142724271 @default.
• W3124193465 hasConcept C168563851 @default.
• W3124193465 hasConcept C204787440 @default.
• W3124193465 hasConcept C27081682 @default.
• W3124193465 hasConcept C2776478404 @default.
• W3124193465 hasConcept C2778525890 @default.
• W3124193465 hasConcept C2778653478 @default.
• W3124193465 hasConcept C2780243291 @default.
• W3124193465 hasConcept C71924100 @default.
• W3124193465 hasConcept C90924648 @default.
• W3124193465 hasConceptScore W3124193465C126322002 @default.
• W3124193465 hasConceptScore W3124193465C126894567 @default.
• W3124193465 hasConceptScore W3124193465C142724271 @default.
• W3124193465 hasConceptScore W3124193465C168563851 @default.
• W3124193465 hasConceptScore W3124193465C204787440 @default.
• W3124193465 hasConceptScore W3124193465C27081682 @default.
• W3124193465 hasConceptScore W3124193465C2776478404 @default.
• W3124193465 hasConceptScore W3124193465C2778525890 @default.
• W3124193465 hasConceptScore W3124193465C2778653478 @default.
• W3124193465 hasConceptScore W3124193465C2780243291 @default.
• W3124193465 hasConceptScore W3124193465C71924100 @default.
• W3124193465 hasConceptScore W3124193465C90924648 @default.
• W3124193465 hasFunder F4320321001 @default.
• W3124193465 hasFunder F4320324174 @default.
• W3124193465 hasIssue "5" @default.
• W3124193465 hasLocation W31241934651 @default.
• W3124193465 hasLocation W31241934652 @default.

• next